Janssen, Celltrion Brawl Over Fed. Circ. Biosimilar Ruling
Janssen Biotech Inc. and Celltrion Inc. are squaring off in Massachusetts federal court with competing views of a recent Federal Circuit interpretation of the Biologics Price Competition and Innovation Act, debating...To view the full article, register now.
Already a subscriber? Click here to view full article